ASCO: Phase I Cancer Drug Trials Benefit From Precision Medicine
Better outcomes for patients whose treatment is selected based on molecular characteristics of tumor
Strategies Can Help Streamline Revenue-Related Processes
They can be employed to help maximize amount of time available for patient care
ASCO: Pembrolizumab Improves Survival in Melanoma
Three-year overall survival rate of 40 percent; median overall survival of 24.4 months
Burnout, Lack of Job Satisfaction Driving Doctors to Cut Hours
Full-time physicians reporting worsening burnout or decreasing job satisfaction more likely to cut hours
Direct-to-Consumer Dermatology Telemedicine Value Unclear
Concerns raised in relation to skin disease diagnosis and treatment by many telemedicine websites
Sexual Harassment Experienced by One-Third of Female Doctors
And two-thirds say they experience gender bias in workplace
Alexandrite Laser Safe, Effective for Port Wine Stains
3 ms pulse more effective than 5 or 10 ms, especially for purple hypertrophic
ATS: Aggressive Melanoma Linked to Severe, Untreated Sleep Apnea
Study highlights the importance of diagnosing and treating obstructive sleep apnea
Temporary Skin Tattoos Can Evoke Delayed Hypersensitivity
10-year-old presented with erythematous, pruritic, papulovesicular rash after black henna tattoo
Lower Levels of Vitamin D Receptors in Alopecia
Significantly lower serum and tissue VDR levels in alopecia areata, androgenetic alopecia
